European Regulatory Strategy ‘Should Prioritize Real World Evidence’

Innovative Clinical Trials Should Be Priority Too, Says EFPIA.

EFPIA, the European Federation of Pharmaceutical Industries and Associations, has put forward what it thinks the European regulatory network strategy to 2025 should prioritize.

RailTrack
EFPIA Sets Out Its Priorities for Regulatory Stratergy

The European medicines agencies network strategy to 2025 could be crucial for bringing the next wave of innovation to patients, however it needs to focus its priorities to be truly effective, according to EFPIA, the European Federation of Pharmaceutical Industries and Associations. The strategy should shine a spotlight on developing a better, more iterative system for regulatory advice and encouraging innovative clinical trials.

EFPIA’s comments come in response to a consultation on the draft European medicines agencies network strategy to 2025. The draft...

More from Europe

More from Geography